Unlock instant, AI-driven research and patent intelligence for your innovation.
Synthesis of beta-l-2'-deoxy nucleosides
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A deoxynucleoside and nucleoside technology, applied in organic chemistry, sugar derivatives, etc., can solve the problems of flammable dioxane and unsuitable industrial methods
Inactive Publication Date: 2009-04-08
NOVARTIS AG
View PDF38 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0081] Even though McGee et al. reported their method to be scalable for industrial purposes, dioxane is known to be flammable and prone to peroxide formation, making it unsuitable for industrial use
Additionally, McGee et al. do not take into account whether their method generates the D- or L-enantiomer of 2'-deoxythymidine or requires separation of the enantiomers
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
preparation example Construction
[0174] In a first embodiment, 2'-deoxythymidine ( Figure 4 ). The synthesis method comprises: (a) first oxidizing D-xylose with aqueous bromine, then acetic acid and hydrobromic acid to form 2,5-dibromo-2,5-dideoxy-D-lyxenoic acid-1, 4-lactone (2); (b) reacting the lactone product of step (a) with potassium iodide in trifluoroacetic acid (TFA) to give the corresponding 5-iodo compound, i.e. selective removal of the C-2 bromine atom , to obtain 5-iodo-2-deoxylactone (3); (c) treating 5-iodo-2-deoxylactone with potassium hydroxide aqueous solution to obtain 4,5-epoxidized derivatives (4); (d ) Treat 4,5-epoxidized derivatives with aqueous acid to generate corresponding 2-deoxy-L-ribonolactone (5) through C-4 stereospecific conversion; (e) by combining with any protecting group such as Reaction of toluoyl chloride in TEA protects the C-3 and C-5 positions (6); (f) Selective reduction of the protected 2-deoxy-L-ribonolactone with Red-Al reducing agent gives the corresponding in...
Embodiment 1
[0249] The L-arabinose is converted to the corresponding methyloside and the 3- and 4-hydroxyl groups are protected as acetonated derivatives. The following scheme shows a method for deoxidizing the 2-hydroxyl group of compound 2 by converting the hydroxyl group to the corresponding mesylate group and subjecting the mesylate intermediate to reductive cleavage conditions to give 2-deoxy intermediate 4. See H. Urata, E. Ogura, K. Shinohara, Y. Ueda and M Akagi, Nucleic Acids Res. 1992, 20, 3325-3332; and J.W. Pratt, N.K. Richtmyer and C.S. Hudson, J. Am. Chem. Soc. 1952, 74, 2200-2205.
[0250] Start with L-arabinose
[0251]
Embodiment 2
[0253]The conversion of L-arabinose to the corresponding enose derivatives and the conversion of the resulting enose intermediates to methyl 2-deoxyribofuranosides is accomplished through key reductive elimination steps. See B. K. Shull, Z. Wu and M. Koreeda, J. Carbohydr. Chem. 1996, 15, 955-964; M. L. Sznaidman, M. R. Almond and A. Pesyan. Nucleosides, Nucleotides & Nucleic Acids 2002, 21, 155-163; and Z.-X. Wang, W. Duan, L.I. Wiebe, J. Balzarini, E.D. Clercq and E.E. Knaus, Nucleosides, Nucleotides & Nucleic Acids 2001, 20, 11-40.
[0254]
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
An improved process for the preparation of 2'-modified nucleosides and 2'-deoxy-nucleosides, such as, beta-L-2'-deoxy-thymidine (LdT), is provided. In particular, the improved process is directed to the synthesis of a 2'-deoxynucleoside that may utilize different starting materials but that proceeds via a chloro-sugar intermediate or via a 2,2' anhydro-1-furanosyl-nucleobase intermediate. Where an 2,2'-anhydro-1-furanosyl base intermediate is utilized, a reducing agent, such as Red-Al, and a sequestering agent, such as 15-crown-5 ether, that cause an intramolecular displacement reaction and formation of the desired nucleoside product in good yields are employed. An alternative process of the present invention utilizes a 2,2'-anhydro-1-furanosyl base intermediate without a sequestering agent to afford 2'-deoxynucleosides in good yields. The compounds made according to the present invention may be used as intermediates in the preparation of other nucleoside analogues, or may be used directly as antiviral and / or antineoplastic agents.
Description
[0001] Cross References to Related Applications [0002] This application claims priority to US Provisional Application No. 60 / 483,711, filed June 30, 2003, and US Provisional Application No. 60 / 558,616, filed April 1, 2004. field of invention [0003] The present invention belongs to the field of preparation methods of 2'-deoxy- or 2'-modified-nucleosides, especially β-L-2'-deoxythymidine. The present invention is an improved method for easy industrial scale production. The compounds prepared according to the method of the present invention are important antiviral drugs, antineoplastic drugs and intermediates in synthetic pharmaceutical compounds and compositions. Background of the invention [0004] HBV is second only to smoking as a cause of human cancer. The mechanism by which HBV induces cancer is unknown, although it is hypothesized that it may trigger tumor development directly, or through infection-related chronic inflammation, liver cirrhosis, and cellular regener...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.